Navinci to attend NextGen Omics and Spatial Biology US as silver sponsor and pre-launch new multiplex kit

Uppsala, Sweden – March 27, 2026 – Navinci announced today its attendance at the Oxford Global Event 'NextGen Omics and Spatial Biology US’ taking place in Boston, USA, March 31-April 1.

NextGen Omics & Spatial Biology connects thought leaders, researchers, and experts with pharmaceutical & biotech representatives to discuss the latest innovations across the fields of multi-omics. The conference focuses on driving the next generation of multi-omics research, featuring topics on spatial biology, in situ multi-omics, and AI-driven data analysis.

At the event, Navinci will pre-launch its new multiplex protein kit, Omni, which will be available for shipment starting in May. Navinci’s proprietary technology enables researchers to simultaneously detect multiple protein targets, protein–protein interactions, and phosphorylation events within a single assay. With access to a large library of verified and pre-conjugated targets, researchers can design assays with the widest range of combinations available in the industry -providing rich spatial context. This opens the door to powerful new possibilities in, for example, mapping signaling pathways, understanding target activation and microenvironment effects.

Navinci technology will also be represented in a talk on day 1 by Steven R. Barthel, PhD, Assistant Professor of Dermatology at Harvard Medical School and Co-Director of the Program of Glyco-Immunology and Oncology (PGIO) and Research Associate at Mass General Brigham. In this talk, they will showcase how they have used the Glysite Explorer, a powerful new solution developed in collaboration with Vector Laboratories designed to overcome the challenges of studying protein glycosylation.

Navinci representatives will be available throughout the conference and can be found at booth 30. We look forward to meeting you there.

For further information, please contact:

Jenny Sundqvist, CEO

E-mail: jenny.sundqvist@navinci.se

Kjell Ruth, CCO

E-mail: kjell.ruth@navinci.se

About Navinci

Navinci is a Swedish biotech company specializing in developing innovative solutions for studying in situ protein expression and interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.